Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: final results from the Phase II L-MIND study

J Düll, P Abrisqueta, M Andre, M Augustin, G Gaidano, EG Barca, W Jurczak, N Kalakonda, AM Liberati, KJ Maddocks, T Menne, Z Nagy, O Tournilhac, A Bakuli, A Amin, K Gurbanov, G Salles

Research output: Contribution to journalpublished Abstract (Journal)peer-review

Original languageEnglish
Pages (from-to)214
Number of pages1
JournalOncology Research and Treatment
Publication statusPublished - 2023

Cite this